RT @davidludwigmd: Among a large group of veterans with type 2 diabetes, the cardiovascular benefit of intensive drug treatment did not per…
RT @nakajimatoshio_: レガシー効果確認されずなのか。 UKPDS後フォローで得られたレガシー効果とこの報告、どう整合して解釈したらよいのだろう。 UKPDS後10年以上観察と、このVADT15年観察とは背景が違うのだろうか。 https://t.co/Lsq…
レガシー効果確認されずなのか。 UKPDS後フォローで得られたレガシー効果とこの報告、どう整合して解釈したらよいのだろう。 UKPDS後10年以上観察と、このVADT15年観察とは背景が違うのだろうか。
No observed "legacy effect" in CV outcomes with intensive glucose control in the VADT study: https://t.co/QoEemAD8x1 @NEJM
RT @davidludwigmd: Among a large group of veterans with type 2 diabetes, the cardiovascular benefit of intensive drug treatment did not per…
RT @davidludwigmd: Among a large group of veterans with type 2 diabetes, the cardiovascular benefit of intensive drug treatment did not per…
RT @Drlipid: In VADT study among veterans with T2 diabetes, “intensive glucose control" was no help for reducing long-term risk of CV event…
RT @NEJM: The VADT follow-up study was designed to examine long-term consequences of intensive glycemic control on cardiovascular disease o…
RT @davidludwigmd: Among a large group of veterans with type 2 diabetes, the cardiovascular benefit of intensive drug treatment did not per…
RT @caminalm: Intensive Glucose Control in Patients with Type 2 Diabetes — 15-Year Follow-up | NEJM https://t.co/RXocm6uKVL
RT @davidludwigmd: Among a large group of veterans with type 2 diabetes, the cardiovascular benefit of intensive drug treatment did not per…
RT @davidludwigmd: Among a large group of veterans with type 2 diabetes, the cardiovascular benefit of intensive drug treatment did not per…
RT @davidludwigmd: Among a large group of veterans with type 2 diabetes, the cardiovascular benefit of intensive drug treatment did not per…
In VADT study among veterans with T2 diabetes, “intensive glucose control" was no help for reducing long-term risk of CV events. Hopefully there would be different (+) CV results using todays Rx choices. https://t.co/ilILEX29IQ